Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk (Q33697958)

28 July 2017

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk (English)

1 reference

28 July 2017

0 references

0 references

14

Helen Rees

1 reference

28 July 2017

5

Connie Celum

1 reference

Partners in Prevention HSV/HIV Transmission Study Team

28 July 2017

17

object named as

Partners in Prevention HSV/HIV Transmission Study Team

1 reference

28 July 2017

15

Lawrence Corey

1 reference

28 July 2017

Deborah Donnell

8

0 references

Anna Wald

object named as

Anna Wald

16

0 references

Carey Farquhar

10

object named as

Carey Farquhar

1 reference

28 July 2017

6

Glenda E Gray

1 reference

28 July 2017

12

James I Mullins

1 reference

28 July 2017

13

Robert W Coombs

1 reference

28 July 2017

4

Jared M Baeten

1 reference

28 July 2017

1

Jairam R Lingappa

1 reference

28 July 2017

11

M Essex

1 reference

28 July 2017

7

Wendy S Stevens

1 reference

28 July 2017

James P Hughes

2

1 reference

28 July 2017

Richard S Wang

3

1 reference

28 July 2017

Mary S Campbell

9

1 reference

28 July 2017

language of work or name

English

0 references

publication date

13 September 2010

1 reference

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

9

1 reference

28 July 2017

e12598

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

start time

13 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effect of treating co-infections on HIV-1 viral load: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Challenges in implementing HIV load testing in South Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Use of predictive markers of HIV disease progression in vaccine trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

HIV-1 transmission, by stage of infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938354

Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012598

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012598

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012598

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20856886

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0012598

1 reference

28 July 2017

0 references

1 reference

28 July 2017

1 reference